Products are selected by our editors, we may earn commission from links on this page.
Health and Human Services Secretary Robert F. Kennedy Jr. has a message for smokers: put down the cigarette and pick up a nicotine pouch instead. He’s called the tiny pouches “probably the safest way to consume nicotine,” and he’s not alone. Across TikTok and Instagram, wellness influencers are pushing the same idea, framing nicotine as a focus booster instead of a warning label. Doctors say the real story is more complicated.
This article was created with the assistance of AI and reviewed by our editorial team for accuracy and clarity.
Kennedy’s Claim Wasn’t a One-Time Slip
Speaking on Fox & Friends, Kennedy said nicotine itself doesn’t cause cancer and that there’s no evidence it’s carcinogenic. He’s repeated the pouches-over-cigarettes stance in multiple interviews, ranking pouches above vapes and cigarettes on his personal safety scale. His stated goal is cutting the roughly $640 billion the U.S. spends yearly on smoking-related health costs. Critics argue he’s skipping over what actually happens once nicotine enters the body.
Even Tech Offices Are Handing Out Pouches Now
The pro-nicotine messaging has spread well beyond politics. Some tech companies like Palantir have started gifting nicotine pouches to employees, marketed as a productivity tool rather than a habit to manage. Combined with influencer claims about energy and relaxation, the product has shed its old stigma fast. Doctors watching the trend say the shift in perception is happening much faster than the science backing it up.
Not All Nicotine Is Built the Same Way
Dr. Frank Leone of the University of Pennsylvania says the comparison to quit-smoking aids like nicotine gum or patches falls apart under scrutiny. Those products use plant-sourced nicotine that’s purified and metered. Newer pouches and vapes rely on a synthetic version engineered for rapid brain absorption. That speed, Leone explains, is exactly what drives addiction. Patches and gum are also meant to be temporary. Pouches, he notes, often aren’t used with any end date in mind.
The Dose Gap Is Bigger Than Most Users Realize
Quit-smoking nicotine gum typically contains 2 to 4 milligrams per piece, according to Dr. Pamela Ling of UCSF. Popular pouch brands start at 3 milligrams and climb to 6. Some brands go far higher, reaching 9, 12, or even 15 milligrams per pouch. Some users double up, placing two pouches in their mouth at once to intensify the effect, a practice doctors say leaves nicotine levels almost impossible to track.
The Cancer Question Isn’t As Settled As Kennedy Suggests
Ling agrees nicotine alone isn’t classified as a carcinogen. But she cautions that cancer takes years to develop, and today’s high-dose pouches and vapes have only existed for a handful of years. Studies on young people who vape but never smoked cigarettes have already found DNA changes in mouth and throat cells matching those seen in longtime smokers. The long-term picture, she says, is still being written in real time.
The “Focus Boost” Claim Has a Funding Problem
Some studies do suggest nicotine can sharpen attention on narrow, simple tasks. But Ling points out that a lot of that research was funded by people tied to tobacco companies, and results outside those studies are mixed at best. Leone compares the influencer pitch to a viral productivity hack: it sounds convincing in a short clip, but the benefits tend to fall apart once someone actually tries to build a routine around them.
The Relaxation Pitch May Be Working Against Users
Nicotine interferes with the brain pathway that manages the body’s stress response, disrupting how the adrenal gland releases cortisol, Leone explains. Instead of reducing stress, it can make the body worse at handling it without nicotine present. That raises an uncomfortable question for regular users. Are the pouches actually calming them down, or has nicotine simply made it harder to feel calm without reaching for one first?
Young Users Face the Steepest Risk
An estimated 400,000 American teenagers already use nicotine pouches, and the category keeps expanding, with Zyn alone projected for tens of billions in sales growth. Ling warns young brains are especially vulnerable because they’re still developing, making addiction take hold faster and harder to shake. Nicotine prompts the brain to grow more receptors craving it, a change that’s tougher to reverse the earlier it starts.
The Bottom Line Doctors Want Americans to Hear
Leone says he has nothing against nicotine as a chemical. The problem, he argues, is how it’s manufactured, packaged, and marketed, and the expectations users bring to it. If someone hasn’t started using nicotine, doctors say there’s no health reason to begin now. Any short-term boost in focus or calm comes bundled with addiction risk, brain changes, and long-term unknowns science hasn’t finished measuring yet.